Tinea corporis Market Trends and Industry Analysis & Forecast to 2023
Posted by Rohit Kamble on March 5th, 2019
Tinea Corporis Market Highlights:
Tinea corporis is a skin infection of arms and legs and it can also occur on any part of body. Tinea corporis is mainly caused by fungus known as dermatophyte. This infection can also acquire from person to person via direct skin contact with the infected person. It is most commonly known as ringworm infection. This infection can also spread from different other sources such as hair brushes, combs, bed linen, of affected person.
Tinea Corporis Market to grow 7.2% CAGR during the Forecast Period 2018 to 2023.
Tinea corporis market is expected to grow in the near future due to rise in incidence of fungal diseases, increasing research and development activities to develop antifungal products and developing healthcare sector. Key players in market are making their position in many developing countries due to the FDI policies regulated within the pharmaceuticals industry in such countries with increasing consumer demands towards maintaining aesthetic appearance is also driving the market for global tinea corporis.
Get Sample Research Report at https://www.marketresearchfuture.com/sample_request/6838
Global tinea corporis market is segmented into drug type, diagnosis, treatment and end-users. Tinea corporis market on basis of drug types is segmented into antifungals, steroids and anti-infective combinations.
Based on diagnosis tinea corporis market is segmented into physical exam, imaging tests. Imaging test is further sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy and others.
Based on treatment tinea corporis market is segmented into antifungal shampoos, antifungal creams, drugs and others.
On basis of end-user market is further segmented into hospital pharmacies, drug stores, online pharmacies, dermatology hospitals, medical research centres, academic institutes others.
Some of the key players in the global tinea corporis market are Teva Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc, NorthStar Rx LLC, Aurobindo Pharma Limited, and Camber Pharmaceuticals, Inc., AvKare, Inc., Novartis AG, Sebela Pharmaceuticals, Inc., Bayer AG, Blueberry Therapeutics Ltd, Perrigo Company, Taro Pharmaceuticals., Inc., Breckenridge Pharmaceutical, Inc.
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Like it? Share it!
About the AuthorRohit Kamble
Joined: February 25th, 2019
Articles Posted: 194
More by this author